NeuroFlow, a software platform used by Philadelphia-based Jefferson Health and other clinical clients to monitor and treat patients' behavioral health, announced on Dec. 16 the close of a $7.5 million Series A funding round.
The funding will be used to grow its team and to expand its product integrations and data science to improve the platform's reach and capabilities. The deal was led by Mark Goldstein, a partner at venture firm Builders VC and chair of the UCSF Health Hub, which recently honored NeuroFlow among the finalists of its Digital Health Awards.
"In the sea of mental health solutions, NeuroFlow stood out to us as being the one that was most 'clinical grade,'" Mr. Goldstein said in the announcement. "They had the only solution we found that effectively connects providers and care teams to the right information and mental health resources to make their care more effective."
NeuroFlow is used by more than 200 healthcare facilities across the country, counting approximately 25,000 patients on its platform, which uses EHR integration, risk stratification and natural language processing for more efficient mental healthcare management.